首页> 外国专利> 1H-IMIDAZO(4,5-B)PYRAZIN-2-ONES AND PROCESSES FOR THEIR PREPARATION

1H-IMIDAZO(4,5-B)PYRAZIN-2-ONES AND PROCESSES FOR THEIR PREPARATION

机译:1H-咪唑并(4,5-B)吡嗪-2-酮及其制备方法

摘要

1,219,255. 1H - imidazo[4,5-b]pyrazin- 2- ones. MERCK & CO. Inc. 8 April, 1969 [12 April, 1968], No. 17825/69. Heading C2C. The invention comprises compounds of formula wherein RSP1/SP is H, C 2-6 alkylcarbonyl, C 3-7 cycloalkyl, C 3-5 alkenyl, (C 1-3 alkoxy)carbonyl, C 1-5 alkyl, C 1-5 hydroxyalkyl, (C 1-3 alkoxy)-C 1-3 - alkyl, RCH 2 (R = morpholino, piperazino, piperidino, amino, C 1-5 alkylamino, or di-C 1-5 - alkyl-amino), 1-(C 1-3 -alkoxy)carbonyl-C 1-5 -alkyl or 1-(RSP111/SP) 2 NNHCO-C 1-5 -alkyl (RSP111/SP = H or C 1-3 alkyl); RSP2/SP is as defined for RSP1/SP except C 3-5 alkenyl, C 1-5 hydroxyalkyl, (C 1-3 alkoxy)-C 1-3 - alkyl, NH 2 CH 2 or (C 1-5 alkyl)NHCH 2 ; RSP3/SP is H, C 1-5 alkyl, C 3-5 alkenyl, C 3-8 cycloalkyl, C 1-5 hydroxyalkyl, (C 1-3 alkoxy)-C 1-5 alkyl, phenyl- C 1-5 alkyl, (C 1-5 alkoxy)carbonyl-C 1-5 -alkyl, (mononuclear aroyl)-C 1-5 -alkyl, cyano-C 1-5 -alkyl or heterocyclic-substituted C 1-5 alkyl (the heterocyclic ring containing 5 or 6 members including 1 or 2 N atoms); X is H or halogen, and Y is O or S. These compounds may be prepared by (a) reacting an appropriately substituted 3-aminopyrazinoic acid hydrazide with HNO 2 and heating the 3-aminopyrazinoic acid azide so formed; (b) effecting substitution of the compounds of the above formula wherein RSP1/SP and/or RSP2/SP is hydrogen; (c) reacting the above compounds where RSP1/SP and/or RSP2/SP is 1-(C 1-3 - alkoxy)carbonyl-C 1-5 -alkyl, with N 2 H 4 . The hydrazides for method (a) are prepared from esters of substituted 3-aminopyrazinoic acids. Therapeutic compositions, for administration orally or by injection, comprise compounds of the above formula which are antihypertensive agents with some diuretic and saluretic activity.
机译:1,219,255。 1H-咪唑并[4,5-b]吡嗪-2-。 MERCK&CO。Inc.,1969年4月8日[1968年4月12日],第17825/69号。标题C2C。本发明包含下式的化合物,其中R SP 1是H,C 2-6烷基羰基,C 3-7环烷基,C 3-5烯基,(C 1-3烷氧基)羰基,C 1-5烷基,C 1-5羟烷基,(C 1-3烷氧基)-C 1-3-烷基,RCH 2(R =吗啉代,哌嗪子基,哌啶子基,氨基,C 1-5烷基氨基或二-C 1-5-烷基-氨基),1-(C 1-3-烷氧基)羰基-C 1-5-烷基或1-(R 111 )2 NNHCO-C 1-5-烷基(R 111 = H或C 1-3烷基);除了C 3-5烯基,C 1-5羟烷基,(C 1-3烷氧基)-C 1-3-烷基外,R 2 与R 1 相同。 NH 2 CH 2或(C 1-5烷基)NHCH 2; R 3 是H,C 1-5烷基,C 3-5烯基,C 3-8环烷基,C 1-5羟烷基,(C 1-3烷氧基)-C 1-5烷基,苯基-C 1-5烷基,(C 1-5烷氧基)羰基-C 1-5烷基,(单核芳酰基)-C 1-5烷基,氰基-C 1-5烷基或杂环取代的C 1 -5烷基(含有1或2个N原子的5或6个成员的杂环); X是H或卤素,Y是O或S。这些化合物可通过(a)使适当取代的3-氨基吡嗪酸酰肼与HNO 2反应并加热形成的3-氨基吡嗪酸叠氮化物来制备。 (b)取代上式的化合物,其中R 1 和/或R 2 是氢; (c)使其中R 1 和/或R 2 为1-(C 1-3-烷氧基)羰基-C 1-5-烷基的上述化合物与N 2 H 4。方法(a)的酰肼由取代的3-氨基吡嗪酸的酯制备。口服或注射给药的治疗组合物包括上式化合物,它们是具有一定利尿和利尿作用的降压药。

著录项

  • 公开/公告号FR2007444A1

    专利类型

  • 公开/公告日1970-01-09

    原文格式PDF

  • 申请/专利权人 MERCK ET CO;

    申请/专利号FR19690011222

  • 发明设计人

    申请日1969-04-11

  • 分类号A61K27/00;C07D57/00;

  • 国家 FR

  • 入库时间 2022-08-23 10:39:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号